Abstract:To conveniently and effectively cure heart valve diseases or defects, combined with transcatheter valve technology, bioprosthetic heart valves (BHVs) originated from the decellularized porcine pericardium (D-PP) have been broadly used in clinics. Unfortunately, most clinically available BHVs crosslinked with glutaraldehyde (GA) were challenged in their long-term tolerance, degenerative structural changes, and even failure, owing to the synergistic impact of multitudinous elements (cytotoxicity, calcification, immune responses, etc.). In this work, dialdehyde pectin (AP) was prepared by oxidizing the o-dihydroxy of pectin with sodium periodate. Hereafter, the AP-fixed PP model was obtained by crosslinking D-PP with AP with high aldehyde content (6.85 mmol g-1), for acquiring excellent mechanical properties and outstanding biocompatibility. To further improve the hemocompatibility of the AP-fixed PP, a natural and specific inhibitor of thrombin (hirudin) was introduced to achieve surface modification of the AP-fixed PP. The feasibility of crosslinking and functionalizing AP-fixed PP, which was a potential leaflet material of BHVs, was exhaustively and systematically evaluated. In vitro studies found that hirudin-loaded and AP-fixed PP (AP + Hirudin-PP) had synchronously achieved effective fixation of collagen, highly effective anticoagulation, and good HUVECs-cytocompatibility. In vivo results revealed that the AP + Hirudin-PP specimens recruited the minimum immune cells in the implantation experiment, and also presented an excellent anti-calcification effect. Overall, AP + Hirudin-PP was endowed with competitive collagen stability (compared with GA-fixed PP), excellent hemocompatibility, good HUVECs-cytocompatibility, low immunogenicity and outstanding anti-calcification, suggesting that AP + Hirudin-PP might be a promising alternative to GA-fixed PP and exhibited a bright prospect in the clinical applications of BHVs.

A Strategy of Functional Crosslinking Acellular Matrix in Blood-Contacting Implantable Devices with Recombinant Humanized Collagen Type III (Rhcoliii)

Bioinspired, Artificial, Small-Diameter Vascular Grafts with Selective and Rapid Endothelialization Based on an Amniotic Membrane-Derived Hydrogel.

Optimizing Small-Diameter Vascular Grafts: Harnessing the Power of Recombinant Human Type III Collagen (rhcoliii) for Enhanced Antiplatelet and Endothelialization Performance

A tailored extracellular matrix (ECM) - Mimetic coating for cardiovascular stents by stepwise assembly of hyaluronic acid and recombinant human type III collagen

Ulvan mediated VE cadherin antibody and REDV peptide co-modification to improve endothelialization potential of bioprosthetic heart valves

A method for simultaneously crosslinking and functionalizing extracellular matrix-based biomaterials as bioprosthetic heart valves with enhanced endothelialization and reduced inflammation

Cross-Linking Methacrylated Porcine Pericardium by Radical Polymerization Confers Enhanced Extracellular Matrix Stability, Reduced Calcification, and Mitigated Immune Response to Bioprosthetic Heart Valves.

Fabrication and Performance Evaluation of PLCL-hCOLIII Small-Diameter Vascular Grafts Crosslinked with Procyanidins

Study on the Effect of Type III Recombinant Humanized Collagen on Human Vascular Endothelial Cells

Radical polymerization-crosslinking method for improving extracellular matrix stability in bioprosthetic heart valves with reduced potential for calcification and inflammatory response.

A strategy for mechanically integrating robust hydrogel-tissue hybrid to promote the anti-calcification and endothelialization of bioprosthetic heart valve

An extracellular matrix-mimetic coating with dual bionics for cardiovascular stents

Inflammation-responsive PCL/gelatin microfiber scaffold with sustained nitric oxide generation and heparin release for blood-contacting implants

Cartilage Regeneration Achieved in Photo-Crosslinked Hyaluronic Hydrogel Bioactivated by Recombinant Humanized Collagen Type III

Progress in various crosslinking modification for acellular matrix

Biomatrix/polymer composite material for heart valve tissue engineering

Tailored extracellular matrix-mimetic coating facilitates reendothelialization and tissue healing of cardiac occluders

Engineering Collagen-Based Biomaterials for Cardiovascular Medicine

Abstract 4141282: Cystamine/Pentagalloylglucose-based Versatile Modification Strategy of Decellularized Porcine Pericardium for Transcatheter Tissue Engineered Heart Valves

Dialdehyde Pectin-Crosslinked and Hirudin-Loaded Decellularized Porcine Pericardium with Improved Matrix Stability, Enhanced Anti-Calcification and Anticoagulant for Bioprosthetic Heart Valves

Large-Scale Surface Modification of Decellularized Matrix with Erythrocyte Membrane for Promoting in Situ Regeneration of Heart Valve